In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of TG Therapeutics Inc (NASDAQ: TGTX) was $29.61 for the day, up 0.24% from the previous closing price of $29.54. In other words, the price has increased by $0.24 from its previous closing price. On the day, 3.19 million shares were traded. TGTX stock price reached its highest trading level at $30.0 during the session, while it also had its lowest trading level at $28.59.
Ratios:
Our analysis of TGTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 4.59. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 11 ’24 when Lonial Sagar sold 5,000 shares for $30.44 per share. The transaction valued at 152,200 led to the insider holds 100,195 shares of the business.
Charney Laurence N sold 25,000 shares of TGTX for $754,875 on Nov 11 ’24. The Director now owns 212,479 shares after completing the transaction at $30.20 per share. On Nov 11 ’24, another insider, Charney Laurence N, who serves as the Director of the company, bought 25,000 shares for $30.19 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 4609240576 and an Enterprise Value of 4152836096. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.67 while its Price-to-Book (P/B) ratio in mrq is 24.00. Its current Enterprise Value per Revenue stands at 15.684 whereas that against EBITDA is -10178.52.
Stock Price History:
Over the past 52 weeks, TGTX has reached a high of $36.50, while it has fallen to a 52-week low of $10.98. The 50-Day Moving Average of the stock is 19.10%, while the 200-Day Moving Average is calculated to be 52.95%.
Shares Statistics:
TGTX traded an average of 3.84M shares per day over the past three months and 5605040 shares per day over the past ten days. A total of 151.42M shares are outstanding, with a floating share count of 140.30M. Insiders hold about 9.87% of the company’s shares, while institutions hold 65.24% stake in the company. Shares short for TGTX as of 1730332800 were 31998673 with a Short Ratio of 8.34, compared to 1727654400 on 34398243. Therefore, it implies a Short% of Shares Outstanding of 31998673 and a Short% of Float of 22.690001000000002.
